Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANO1 | Q5XXA6 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | CETP | P11597 | 1/20 | 0.30 |
| ▸ | DPP4 | P27487 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15116433 | 0.82 | SMN1; SMN2 (0.35) | ANO1CETPDPP4 | |
| SCHEMBL15125084 | 0.80 | SMN1; SMN2 (0.36) | DPP4 | |
| SCHEMBL15116394 | 0.77 | SMN1; SMN2 (0.36) | DPP4 | |
| SCHEMBL15124802 | 0.76 | ANO1 (0.32) | ANO1DPP4 | |
| SCHEMBL852232 | 0.72 | HDAC3 (0.37) | ANO1DPP4 | |
| SCHEMBL8684589 | 0.72 | ANO1 (0.37) | ANO1CETPDPP4 | |
| SCHEMBL15116430 | 0.72 | SMN1; SMN2 (0.38) | DPP4 | |
| SCHEMBL5143779 | 0.72 | DPP4 (0.35) | ANO1DPP4 | |
| SCHEMBL20054116 | 0.71 | CYP3A4 (0.33) | ANO1NPSR1DPP4 | |
| SCHEMBL8399442 | 0.71 | DPP4 (0.34) | ANO1DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11572370-B2 | CD16A binding agents and uses thereof | BIOHAVEN THERAPEUTICS LTD. (US) | 2023-02-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11572370-B2 | CD16A binding agents and uses thereof | FCGR1A, FCGR2A, FCGR3B | ANO1 1433/4885NPSR1 518/4885CETP 2554/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.